✦ LIBER ✦

Meta-Analysis Of The Efficacy And Safety Of Bortezomib (Btz) Retreatment In Patients (Pts) With Multiple Myeloma (Mm)

✍ Scribed by Knopf, K.; Duh, M.S.; Lafeuille, M.H.; Gravel, J.; Lefebvre, P.; Niculescu, L.; Ba-mancini, A.; Ma, E.; Shi, H.; Comenzo, R.L.

Book ID: 120996750
Publisher: John Wiley and Sons
Year: 2013
Tongue: English
Weight: 73 KB
Volume: 16
Category: Article
ISSN: 1098-3015
DOI: 10.1016/j.jval.2013.03.627

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety and efficacy of bortezomib in hig

Safety and efficacy of bortezomib in high-risk and elderly patients with relapsed multiple myeloma

✍ Paul G. Richardson; Pieter Sonneveld; Michael W. Schuster; David Irwin; Edward A 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 519 KB

Efficacy And Safety Of Chemomoblization

Efficacy And Safety Of Chemomoblization With VP-16 And G-CSF In Patients (PTS) Undergoing Autologous Stem Cell Transplantation (ASCT) For Multiple Myeloma (MM)

✍ W.A. Wood; J.S. Whitley; D.T. Moore; A. Sharf; R. Irons; K.V. Rao; J.S. Serody; 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 75 KB

Safety and efficacy of bortezomib-based

Safety and efficacy of bortezomib-based regimens for multiple myeloma patients with renal impairment: a retrospective study of Italian Myeloma Network GIMEMA

✍ Fortunato Morabito; Massimo Gentile; Stefania Ciolli; Maria T. Petrucci; Sara Ga 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 148 KB

The efficacy and safety of bortezomib an

The efficacy and safety of bortezomib and dexamethasone as a maintenance therapy in patients with advanced multiple myeloma who are responsive to salvage bortezomib-containing regimens

✍ Giulia Benevolo; Alessandra Larocca; Massimo Gentile; Patrizia Pregno; Francesca 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 163 KB 👁 1 views

Bortezomib for patients with previously

Bortezomib for patients with previously untreated multiple myeloma: a systematic review and meta-analysis of randomized controlled trials

✍ Zeng, Zhiyong; Lin, Junfang; Chen, Junmin 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 535 KB

No influence of the polymorphismsCYP2C19

No influence of the polymorphismsCYP2C19andCYP2D6on the efficacy of cyclophosphamide, thalidomide, and bortezomib in patients with Multiple Myeloma

✍ Annette J Vangsted; Karen Søeby; Tobias W Klausen; Niels Abildgaard; Niels F And 📂 Article 📅 2010 🏛 BioMed Central 🌐 English ⚖ 283 KB